11β-hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone in mouse lung microsomes

Cancer Research

Volumn 58, Issue 14, 1998, Pages 2996-3003

  Maser, Edmund ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; ANTIBODY; CARBON; CARBONYL DERIVATIVE; CARBONYL REDUCTASE; CARCINOGEN; CORTICOSTERONE; CYTOCHROME P450; GLYCYRRHETINIC ACID; MESSENGER RNA; NITROSAMINE; NITROSO DERIVATIVE; PREDNISONE; PROTEIN; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; HYDROXYSTEROID DEHYDROGENASE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYLATION; LUNG; MICROSOME; MOUSE; NONHUMAN; OXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOBACCO; ANIMAL; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; OXIDATION REDUCTION REACTION; TOPICAL DRUG ADMINISTRATION;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; FEMALE; GLUCOCORTICOIDS; GLYCYRRHETINIC ACID; HYDROXYSTEROID DEHYDROGENASES; LUNG; MICE; MICROSOMES; NITROSAMINES; OXIDATION-REDUCTION; RNA, MESSENGER;

EID: 0032527123     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. International Agency for Research on Cancer. Tobacco smoking. IARC Monogr. Eval. Carcinog. Risk Chem. Hum., 38: 127-163, 1986.
2. Rivenson, A., Hoffmann, D., Prokopczyk, B., Amin, S., and Hecht, S. S. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res., 48: 6912-6917, 1988.
3. Hecht, S. S., and Hoffmann, D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis (Lond.), 9: 875-884, 1988.
4. Castonguay, A., Lin, D., Stoner, G. D., Radok, P., Furuya, K., Hecht, S. S., Schut, H. A. J., and Klaunig, J. E. Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N′-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and their analogues. Cancer Res., 43: 1223-1229, 1983.
5. Hoffmann, D., and Hecht, S. S. Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions. Cancer Res., 45: 935-944, 1985.
6. Foiles, P. G., Akerkar, S. A., Carmella, S. G., Kagan, M., Stoner, G. D., Resau, J. H., and Hecht, S. S. Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem. Res. Toxicol., 4: 364-368, 1991.
7. 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA. Carcinogenesis (Lond.), 14: 151-154, 1993.
8. Hecht, S. S. Metabolic activation and detoxification of tobacco-specific nitrosamines: a model for cancer prevention strategies. Drug Metab. Rev., 26: 373-390, 1994.
9. Carmella, S. G., Borukhova, A., Akerkar, S. A., and Hecht, S. S. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen. Cancer Epidemiol. Biomark. Prev., 6: 113-120, 1997.
10. Liu, L. L., Alaoui Jamali, M. A., el Alami, N., and Castonguay, A. Metabolism, and DNA single strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes. Cancer Res., 50: 1810-1816, 1990.
11. Jorquera, R., Castonguay, A., and Schuller, H, M. Placental transfer of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone instilled intratracheally in Syrian golden hamsters. Cancer Res., 52: 3273-3280, 1992.
12. Murphy, S. E., Heiblum, R., and Trushin, N. Comparative metabolism of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured F344 rat oral tissue and esophagus. Cancer Res., 50: 4685-4691, 1990.
13. Murphy, S. E., Heiblum, R., King, P. G., Bowman, D., Davis, W. J., and Stoner, G. D. Effect of phenethyl isothiocyanate on the metabolism of tobacco-specific nitrosamines by cultured rat oral tissue. Carcinogenesis (Lond.), 12: 957-961, 1991.
14. Guo, Z., Smith, T. J., Thomas, P. E., and Yang, C. S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats. Arch. Biochem. Biophys., 298: 279-286, 1992.
15. Demkowicz-Dobrzanski, K., and Castonguay, A. Modulation by glutathione of DNA strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its aldehyde metabolites in rat hepatocytes. Carcinogenesis (Lond.), 13: 1447-1454, 1992.
16. Morse, M. A., LaGreca, S. D., Amin, S. G., and Chung, F. L. Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res., 50: 2613-2617, 1990.
17. Rossignol, G., Alaoui Jamali, M. A., Castonguay, A., and Schuller, H. M. Metabolism, and DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in fetal tissues of the Syrian golden hamster. Cancer Res., 49: 5671-5676, 1989.
18. Smith, T. J., Liao, A. M., Liu, Y., Butler Jones, A., Anderson, L. M., and Yang, C. S. Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes. Carcinogenesis (Lond.), 18: 1577-1584, 1997.
19. Murphy, S. E., Nunes, M. G., and Hatala, M. A. Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK. Chem. Biol. Interact., 103: 153-166, 1997.
20. Smith, T. J., Stoner, G. D., and Yang, C. S. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroxyperoxides. Cancer Res., 55: 5566-5573, 1995.
21. Adams, J. D., LaVoie, E. J., and Hoffmann, D. On the pharmacokinetics of tobacco-specific N-nitrosamines in Fisher rats. Carcinogenesis (Lond.), 6: 509-511, 1985.
22. Adams, J. D., LaVoie, E. J., O'Mara-Adams, K. J., Hoffmann, D., Carey, K. D., and Marshall, M. V. Pharmacokinetics of N-nitrosonornicotine and 4-methylnitrosamino-1-(3-pyridyl)-1-butanone in laboratory animals. Cancer Lett., 28: 195-201, 1985.
23. Hecht, S. S., Trushin, N., Reid Quinn, C. A., Burak, E. S., Jones, A. B., Southers, J. L., Gombar, C. T., Carmella, S. G., Anderson, L. M., and Rice, J. M. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis (Lond.), 14: 229-236, 1993.
24. Carmella, S. G., Akerkar, S., and Hecht, S. S. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res., 53: 721-724, 1993.
25. Carmella, S. G., Akerkar, S. A., Richie, J. P., and Hecht, S. S. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smoker's urine. Cancer Epidemiol. Biomark. Prev., 4: 635-652, 1995.
26. Kresty, L. A., Carmella, S. G., Borukhova, A., Akerkar, S. A., Gopalakrishnan, R., Harris, R. E., Stoner, G. D., and Hecht, S. S. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship of urinary biomarkers and oral leukoplakia. Cancer Epidemiol. Biomark. Prev., 5: 521-525, 1996.
27. Hecht, S. S., Carmella, S. G., Murphy, S. E., Akerkar, S., Brunnemann, K. D., and Hoffmann, D. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N. Engl. J. Med., 329: 1543-1546, 1993.
28. Smith, T. J., Guo, Z., Li, C., Ning, S. M., Thomas, P. E., and Yang, C. S. Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate. Cancer Res., 53: 3276-3282, 1993.
29. Smith, T. J., Guo, Z., Hong, J. Y., Ning, S. M., Thomas, P. E., and Yang, C. S. Kinetics and enzyme involvement in the metabolism of 4-(metnylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in microsomes of rat lung and nasal mucosa. Carcinogenesis (Lond.), 13: 1409-1414, 1992.
30. Smith, T. J., Guo, Z. Y., Thomas, P. E., Chung, F. L., Morse, M. A., Elkind, K., and Yang, C. S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates. Cancer Res., 50: 6817-6822, 1990.
31. Schuller, H. M., Castonguay, A., Orloff, M., and Rossignol, G. Modulation of the uptake and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-bulanone by nicotine in hamster lung. Cancer Res., 51: 2009-2014, 1991.
32. Hong, J. Y., Smith, T., Lee, M. J., Li, W. S., Ma, B. L., Ning, S. M., Brady, J. F., Thomas, P. E., and Yang, C. S. Metabolism of carcinogenic nitrosamines by rat nasal mucosa and the effect of diallyl sulfide. Cancer Res., 51: 1509-1514, 1991.
33. Brittebo, E. B., Castonguay, A., Furuya, K., and Hecht, S. S. Metabolism of tobacco-specific nitrosamines by cultured nasal mucosa. Cancer Res., 43: 4343-4348, 1983.
34. Smith, T. J., Guo, Z., Gonzalez, F. J., Guengerich, F. P., Stoner, G. D., and Yang, C. S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res., 52: 1757-1763, 1992.
35. Collazo, N. R., and Sultatos, L. G. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human placental microsomes. Biochem. Pharmacol., 50: 1933-1941, 1995.
36. Seckl, J. R. 11β-Hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation. Eur. J. Clin. Invest., 23: 589-601, 1993.
37. Maser, E., Richter, E., and Friebertshäuser, J. The identification of 11 β-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Eur. J. Biochem., 238: 484-489, 1996.
38. Maser, E., and Bannenberg, G. The purification of 11β-hydroxysteroid dehydrogenase from mouse liver microsomes. J. Steroid Biochem. Mol. Biol., 48: 257-263, 1994.
39. Maser, E., and Bannenberg, G. 11β-Hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds. Biochem. Pharmacol., 47: 1805-1812, 1994.
40. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurements with the Folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
41. Maser, E. 11β-Hydroxysteroid dehydrogenase acts as carbonyl reductase in microsomal Phase I drug metabolism. Exp. Toxicol. Pathol., 48: 266-273, 1996.
42. Wang, Z. Y., Hong, J. Y., Huang, M. T., Reuhl, K. R., Conney, A. H., and Yang, C. S. Inhibition of N-nitrosodiethylamine-and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res., 52: 1943-1947, 1992.
43. Edwards, C. R., Stewart, P. M., Burt, D., Brett, L., McIntyre, M. A., Sutanto, W. S., de Kloet, E. R., and Monder. C. Localisation of 11β-hydroxysteroid dehydrogenase: tissue specific protector of the mineralocorticoid receptor. Lancet, 2: 986-989, 1988.
44. Rekka, E. A., Soldan, M., Belai, I., Netter, K. J., and Maser, E. Biotransformation and detoxification of insecticidal metyrapone analogues by carbonyl reduction in the human liver. Xenobiotica, 26: 1221-1229, 1996.
45. Maser, E. Xenobiotic carbonyl reduction and physiological steroid oxidoreduction: the pluripotency of several hydroxysteroid dehydrogenases. Biochem. Pharmacol., 49: 421-440, 1995.
46. Oppermann, U. C. T., Netter, K. J., and Maser, E. Cloning and primary structure of murine 11β-hydroxysteroid dehydrogenase/microsomal carbonyl reductase. Eur. J. Biochem., 227: 202-208, 1995.
47. Maser, E., Friebertshäuser, J., and Mangoura, S. A. Ontogenic pattern of carbonyl reductase activity of 11β-hydroxysteroid dehydrogenase in mouse liver and kidney. Xenobiotica, 24: 109-117, 1994.
48. Boring, C. C., Squires, T. S., and Tong, T. Cancer statistics. J. Clin. Cancer, 86: 7-26, 1993.
49. Murphy, S. E., Palomino, A., Hecht, S. S., and Hoffmann, D. Dose-response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res., 50: 5446-5452, 1990.
50. Doerr, O. R., Trushin, N., Hecht, S. S., and Stoner, G. D. Effect of phenethyl isothiocyanate on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat lung tissue. Carcinogenesis (Lond.), 12: 1029-1034, 1991.
51. Guo, Z., Smith, T. J., Wang, E., Sadrieh, N., Ma, Q., Thomas, P. E., and Yang, C. S. Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats. Carcinogenesis (Lond.), 13: 2205-2210, 1992.
52. Meger, M., Meger-Kossien, I., Dietrich, M., Tricker, A. R., Scherer, G., and Adlkofer, F. Metabolites of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone in urine of smokers. Eur. J. Cancer Prev., 5 (Suppl. 1): 121-124, 1996.
53. Stewart, P. M., Whorwood, C. B., and Mason, J. I. Type 2 11β-hydroxysteroid dehydrogenase in foetal and adult life. J. Steroid Biochem. Mol. Biol., 55: 465-471, 1995.
54. Witschi, H., load, J. P., and Pinkerton, K. E. The toxicology of environmental tobacco smoke. Annu. Rev. Pharmacol. Toxicol., 37: 29-52, 1997.
55. Sipowicz, M. A., Amin, S., Desai, D., Kasprzak, K. S., and Anderson, L. M. Oxidative DNA damage in tissues of pregnant female mice and fetuses caused by the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer Lett., 117: 87-91, 1997.
56. Maser, E. Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer? Trends Pharmacol. Sci., 18: 270-275, 1997.
57. Seckl, J. R. 11β-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action? Front. Neuroendocrinol., 18: 49-99, 1997.
58. Morse, M. A., Amin, S. G., Hecht, S. S., and Chung, F. L. Effects of aromatic isothiocyanates on tumorigenicity, O6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Cancer Res., 49: 2894-2897, 1989.
59. Morse, M. A., Wang, C. X., Stoner, G. D., Mandai, S., Conran, P. B., Amin, S. G., Hecht, S. S., and Chung, F. L. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation and tumorigenicity in the lung of F344 rats by dietary phenethyl isothiocyanate. Cancer Res., 49: 549-553, 1989.
60. Hecht, S. S., Trushin, N., Rigotty, J., Carmella, S. G., Borukhova, A., Akerkar, S. A., and Rivenson, A. Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate. Cancer Epidemiol. Biomark. Prev., 5: 645-652, 1996.
61. Castonguay, A., and Rioux, N. Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols. Carcinogenesis (Lond.), 18: 491-496, 1997.
62. Hennebold, J. D., Ryu, S. Y., Mu, H. H., Galbraith, A., and Daynes, R. A. 11β-Hydroxysteroid dehydrogenase modulation of glucocorticoid activities in lymphoid organs. Am. J. Physiol., 270: R1296-R1306, 1996.
63. Murphy, S. E., Spina, D. A., Nunes, M. G., and Pullo, D. A. Glucuronidation of 4-((hydroxymethyl)nitrosamino)-1-(3-pyridyl)-1-butanone, a metabolically activated form of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, by phenobarbital-treated rats. Chem. Res. Toxicol., 8: 772-779, 1995.